Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
“Consuming foods high in sugar, such as pastries, can significantly impact your cholesterol profile, primarily by altering ...
VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
LDL cholesterol is an important marker, but others such as ApoB, hs-CRP, and insulin resistance should not be ignored, shares Dr Kumar.
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point ...
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Cholesterol is a waxy substance found in our cells. Cholesterol essentially is not bad for the body as many might think. Cholesterol aids the production of various hormones, vitamins and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results